Taysha Gene Therapies shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $145k | 72k | 2.01 |
| 2024-06-30 | $156k | 70k | 2.24 |
| 2024-03-31 | $21k | 7.4k | 2.87 |
| 2023-12-31 | $13k | 7.4k | 1.77 |
| 2023-09-30 | $21k | 6.5k | 3.16 |
| 2023-06-30 | $13k | 19k | 0.66 |
| 2022-12-31 | $2.9k | 1.3k | 2.26 |
| 2022-09-30 | $0 | 950 | 0.00 |
| 2022-06-30 | $1.0k | 163 | 6.14 |
| 2022-03-31 | $9.0k | 1.4k | 6.23 |
| 2021-12-31 | $110k | 9.5k | 11.63 |
| 2021-03-31 | $1.2M | 57k | 20.31 |
| 2020-12-31 | $330k | 12k | 26.48 |